Emily McWilliams Ph.D.
B.S. Chemistry, North Park University, 2011
Ph.D. Biomedical Sciences – Immunology, The Ohio State University, 2016
Emily started at Dana-Farber as a post-doctoral fellow in the Brown Lab in 2017. Her post-doc research focused on using mass cytometry (CyTOF) to study the role of Treg and Th17 cells in CLL patients developing toxicities during PI3Ki therapy. Emily is now a Research Scientist at DFCI working in the Center for Immuno-Oncology Immune-Assessment Lab. Outside of the lab, Emily enjoys cycling, traveling, and hiking around New England with her wife.